Niagen Bioscience, Inc. (NAGE) Tops Q1 EPS by 4c

Niagen Bioscience, Inc. (NASDAQ: NAGE) reported Q1 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $27.07 million.

For earnings history and earnings-related data on Niagen Bioscience, Inc. (NAGE) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Cytek faces $56M damages award in Beckman Coulter patent case